BRTX - Company ID 0001505497
The table below shows BioRestorative Therapies, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.11M | $602.44K | $1.56M | $1.23M | $1.49M | $2.25M |
| Short-term investments | $479.35K | $3.89M | $5.83M | $7.88M | $11.60M | $12.43M |
| Receivables | $13.30K | $13.40K | $15.00K | $25.00K | $165.00K | $27.40K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $3.80M |
| $4.71M |
| $7.60M |
| $9.36M |
| $13.51M |
| $15.00M |
| Property, plant & equipment | $328.81K | $309.50K | $339.68K | $369.99K | $378.43K | $345.81K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $4.64M | $5.64M | $8.52M | $10.33M | $14.57M | $16.12M |
| Accounts payable | $666.90K | $859.90K | $609.93K | $599.50K | $401.38K | $215.92K |
| Total current liabilities | $1.61M | $3.44M | $3.67M | $4.18M | $4.58M | $5.32M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | $3.67M | $4.18M | $4.58M | $5.32M |
| Retained earnings | -$172.08M | -$166.71M | -$163.67M | -$161.02M | -$154.04M | -$152.95M |
| Total equity | $3.03M | $2.21M | $4.85M | $6.14M | $9.99M | $10.80M |